Overview

Treatment of Ulcerative Colitis With Ciprofloxacin and E. Coli Nissle

Status:
Completed
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
Purpose: The purpose of the study is to investigate if treatment with ciprofloxacin for one week followed by therapy with E. Coli Nissle (EcN) for seven weeks can influence disease activity among ulcerative colitis patients with disease flare-ups compared to placebo controls.
Phase:
Phase 4
Details
Lead Sponsor:
Hvidovre University Hospital
Treatments:
Ciprofloxacin